Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Early Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Early Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01856686Early Phase 1Completed

Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein

Role: collaborator

NCT02136160Not ApplicableCompleted

Population-based Intervention to Promote Health in Elementary Schools

Role: collaborator

NCT00336128Not ApplicableCompleted

Population Based Intervention to Prevent Obesity in Kindergartens (TigerKids)

Role: collaborator

NCT02614599Early Phase 1Completed

Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet

Role: collaborator

All 4 trials loaded